Eligibility for thrombolysis and outcome in pediatric acute ischemic stroke

Background Thrombolysis is infrequently delivered to children with acute ischemic stroke (AIS). Consideration of eligibility criteria and outcomes after AIS may enhance utility of thrombolysis in pediatric AIS.

Methods This retrospective observational study assessed eligibility for acute tissue plasminogen activator (tPA) and outcome in a 10-year population cohort of 151 children with AIS and a first symptomatic AIS cohort of 68 children. Outcomes among children with small vessel AIS, residual brain tumors and intracranial dissection, who are currently excluded from tPA, were explored to assess potential for benefit from tPA in these subgroups.

Results Approximately 80% of each cohort were excluded from tPA, irrespective of delay to diagnosis, related to multiple underlying disorders. All deaths occurred among patients excluded from tPA. The minority eligible for tPA had large vessel occlusions, focal cerebral arteriopathy or extracranial dissections. More than half of eligible patients had non-disabled outcomes without tPA. Approximately 40% of both cohorts had small vessel AIS, more than half of whom were excluded from tPA for additional reasons. Among those not additionally excluded, 78-88% of each cohort had non-disabled outcomes without tPA. Among 12 patients excluded from tPA due to residual brain tumors, all had additional exclusions. In contrast, patients with AIS due to intracranial dissection infrequently had additional cause for exclusion and outcomes were relatively poor.

Conclusions Only 20% of childhood AISs were eligible for tPA, irrespective of delay to diagnosis, and more than half of these patients manifest non-disabled outcomes without tPA, suggesting relatively restricted potential for benefit with tPA. Relaxation of some exclusions for selected patients may enhance beneficial delivery of tPA.